Cargando…
Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases
BACKGROUND: To determine the clinical benefits of systemic targeted agents across multiple histologies after stereotactic radiosurgery (SRS) for brain metastases. METHODS: Between 2000 and 2013, 737 patients underwent upfront SRS for brain metastases. Patients were stratified by whether or not they...
Autores principales: | Johnson, Adam G., Ruiz, Jimmy, Hughes, Ryan, Page, Brandi R., Isom, Scott, Lucas, John T., McTyre, Emory R., Houseknecht, Kristin W., Ayala-Peacock, Diandra N., Bourland, Daniel J., Hinson, William H., Laxton, Adrian W., Tatter, Stephen B., Debinski, Waldemar, Watabe, Kounosuke, Chan, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662466/ https://www.ncbi.nlm.nih.gov/pubmed/26087184 |
Ejemplares similares
-
Sociodemographic predictors of patients with brain metastases treated with stereotactic radiosurgery
por: Alphonse-Sullivan, Natalie, et al.
Publicado: (2017) -
The Effects of smoking status and smoking history on patients with brain metastases from lung cancer
por: Shenker, Rachel F., et al.
Publicado: (2017) -
Collagen deposition within brain metastases is associated with leptomeningeal failure after
cavity-directed radiosurgery
por: Abdulhaleem, Mohammed, et al.
Publicado: (2023) -
Survival and Failure Outcomes Predicted by Brain Metastasis Volumetric Kinetics in Melanoma Patients Following Upfront Treatment with Stereotactic Radiosurgery Alone
por: LeCompte, Michael C, et al.
Publicado: (2017) -
RADI-31. MULTI-INSTITUTIONAL VALIDATION OF BRAIN METASTASIS VELOCITY, A RECENTLY DEFINED PREDICTOR OF OUTCOMES FOLLOWING STEREOTACTIC RADIOSURGERY
por: Chan, Michael, et al.
Publicado: (2019)